We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+28.58%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$3.75B
AUM Growth
+$525M
Cap. Flow
-$632M
Cap. Flow %
-16.88%
Top 10 Hldgs %
81.24%
Holding
87
New
11
Increased
6
Reduced
26
Closed
13

Top Buys

Rank Stock Value
1
NTES icon
NetEase
NTES
+$24M
2
IBKR icon
Interactive Brokers
IBKR
+$10.7M
3
HUNT
Hunter Maritime Acquisition Corp. Common Stock
HUNT
+$9.81M
4
MMYT icon
MakeMyTrip
MMYT
+$7.36M
5
RICE
Rice Energy Inc.
RICE
+$5.75M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$21.2M
2
IBB icon
iShares Biotechnology ETF
IBB
+$18.1M
3
EQC
Equity Commonwealth
EQC
+$17.3M
4
PYPL icon
PayPal
PYPL
+$14.5M
5
HUNTU
Hunter Maritime Acquisition Corp. Unit
HUNTU
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 62.84%
2 Consumer Discretionary 2.9%
3 Communication Services 2.74%
4 Financials 1.95%
5 Energy 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
51
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.16M 0.06%
23,799
-34,718
-59% -$3.16M
NAT icon
52
Nordic American Tanker
NAT
$1.37B
$1.4M 0.04%
+221,760
New +$1.56M
PTN
53
Palatin Technologies
PTN
$13.7M
$1.29M 0.03%
3,437
– –
XBI icon
54
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$1.29M 0.03%
+16,693
New +$1.18M
TCON
55
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$815K 0.02%
1,698
– –
CLLS
56
Cellectis
CLLS
$286M
$655K 0.02%
+25,353
New +$605K
HYG icon
57
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$639K 0.02%
7,235
-10,779
-60% -$949K
AKTX
58
Akari Therapeutics
AKTX
$15.2M
$531K 0.01%
165
-96
-37% -$759K
INSW icon
59
International Seaways
INSW
$4.57B
$397K 0.01%
18,309
– –
BIVV
60
DELISTED
Bioverativ Inc. Common Stock
BIVV
$354K 0.01%
5,879
– –
HUNTW
61
DELISTED
Hunter Maritime Acquisition Corp. Warrant
HUNTW
$16K ﹤0.01%
+500,000
New +$308K
ARWR icon
62
Arrowhead Research
ARWR
$12.1B
– –
-2,556,256
Closed -$4.73M
BIIB icon
63
Biogen
BIIB
$29.9B
– –
-11,760
Closed -$3.21M
DHT icon
64
DHT Holdings
DHT
$2.97B
– –
-1,206,051
Closed -$5.39M
INTC icon
65
Intel
INTC
$466B
– –
-587,314
Closed -$21.2M
PFF icon
66
iShares Preferred and Income Securities ETF
PFF
$13.2B
– –
-51,194
Closed -$1.98M
RGNX icon
67
Regenxbio
RGNX
$623M
– –
-193,432
Closed -$3.73M
ONC
68
BeOne Medicines Ltd
ONC
$33.8B
– –
-170,000
Closed -$6.22M
EQC
69
DELISTED
Equity Commonwealth
EQC
– –
-554,688
Closed -$17.3M
BLCM
70
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-30,072
Closed -$3.71M
EPZM
71
DELISTED
Epizyme, Inc
EPZM
– –
-355,445
Closed -$6.1M
CASC
72
DELISTED
Cascadian Therapeutics, Inc.
CASC
– –
-800,000
Closed -$3.31M
HUNTU
73
DELISTED
Hunter Maritime Acquisition Corp. Unit
HUNTU
– –
-1,000,000
Closed -$10.4M
GLF
74
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
– –
-607,500
Closed -$213K
1 2
3

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q2 2017 Portfolio in Review

As of Q2 2017, QVT Financial held 87 positions worth $3.75B, up 16% from $3.22B the previous quarter. Its ten largest holdings account for 81% of the portfolio.

QVT Financial withdrew a net $632M in Q2 2017, closing 13 positions and reducing 26 holdings. Its most notable exit was Intel, an estimated $21.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 56% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, QVT Financial opened a new position in NetEase worth $25.2M.

  • QVT Financial's largest Q2 2017 buy was NetEase: 418,950 shares worth $25.2M.
  • QVT Financial added most to MakeMyTrip in Q2 2017, an estimated $7.36M increase.
  • QVT Financial's biggest Q2 2017 reduction was iShares Biotechnology ETF, cutting an estimated $18.1M.
  • QVT Financial fully exited Intel in Q2 2017, selling an estimated $21.2M.
  • QVT Financial's ten largest holdings make up 81% of its $3.75B portfolio in Q2 2017.
  • QVT Financial opened 11 new positions and closed 13 in Q2 2017.
  • QVT Financial's portfolio value rose 16% quarter-over-quarter to $3.75B.

Based on QVT Financial's 13F filing for Q2 2017, filed 14 Aug 2017.